Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Improving the Vaccination Environment to Prevent Respiratory Infectious Diseases in Older Adults and High-Risk Individuals
    Release Date:
    Review Process: Pfizer Internal
    Translation: Japanese (link)
    Quality Improvement Vaccines Japan
    Improving Shared Decision Making in Hemophilia: Visiting Professorship Program - 2026, Semester 2
    Release Date:
    Partner: Hemostasis & Thrombosis Research Society (HTRS)
    Review Process: Expert Review Panel
    Education Rare Disease USA
    Development of Healthcare Professionals with Advanced Expertise in Preventive Strategies in Pediatric Infectious Diseases
    Release Date:
    Review Process: Pfizer Internal
    Translation: Japanese (link)
    Education Vaccines Japan
    Current and Emerging Therapies: The future of Recurrent or Metastatic (r/m) Cervical Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    The Role of RSV in Functional Decline and Healthcare Dependency in Hospitalized Adults
    Release Date:
    Review Process: Expert Review Panel
    Research Vaccines Italy
    Improving the Quality and Standardization of Pneumococcal Diagnostic Pathways in Pediatric and Adult Populations
    Release Date:
    Review Process: Expert Review Panel
    Research Vaccines Italy
    Interventional Research Studies of Brentuximab Vedotin-Based Novel Combinations in AITL and PTCL-NOS
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology USA
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Enhancing awareness and well understanding of the management in hypothalamic pituitary dysfunction, growth disorders
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease Japan
    Long-acting Growth Hormone Research
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease All
    COVID-19: Continuity in Care for Patients with Metastatic Breast Cancer Grant Support Program (United States and Europe)
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology All
    2020 Osteoarthritis and Osteoarthritis Pain- Virtual Learning
    Release Date:
    Partner:

    Lilly

    Review Process: Pfizer Internal
    Education Internal Medicine All
    NASH – Future of Non-invasive Diagnosis Technologies
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine All
    Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Nurse Navigator
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease USA
    Pfizer-ISID 2020 AFME Grant Challenge (Africa and the Middle East)
    Release Date:
    Partner:

    International Society for Infectious Diseases (ISID)

    Review Process: Expert Review Panel
    Quality Improvement Hospital All
    Advances in Oncology Therapy in Renal Cell Carcinoma
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Japan
    Increasing Awareness of Nuclear Scintigraphy in Cardiac Amyloidosis
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease All
    Pfizer and RCNi – Providing Access to Learning Resources for Nurses in the APAC/China Region
    Release Date:
    Partner:

    RCNi (subsidiary of the Royal College of Nursing)

    Review Process: Pfizer Internal
    Education Internal Medicine Hong Kong, India, Indonesia, Malaysia, Pakistan, Philippines, Singapore, Taiwan, Thailand, Vietnam
    Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Latin America
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease Argentina, Brazil, Chile, Colombia
    Vaccine Preventable Diseases – COVID-19 (closed early)
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines All